12:00 AM
Oct 29, 2007
 |  BC Week In Review  |  Company News  |  Deals

Laboratory Corp. of America Holdings, Medco Health Solutions Inc. deal

LH and pharmacy benefit manager MHS partnered to develop a companion diagnostic for tamoxifen, an off-patent selective estrogen receptor modulator (SERM) approved...

Read the full 86 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >